NM_000384.3:c.12809G>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000384.3(APOB):​c.12809G>C​(p.Arg4270Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0302 in 1,613,894 control chromosomes in the GnomAD database, including 1,665 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.054 ( 394 hom., cov: 32)
Exomes 𝑓: 0.028 ( 1271 hom. )

Consequence

APOB
NM_000384.3 missense

Scores

1
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:16

Conservation

PhyloP100: 0.137

Publications

39 publications found
Variant links:
Genes affected
APOB (HGNC:603): (apolipoprotein B) This gene product is the main apolipoprotein of chylomicrons and low density lipoproteins (LDL), and is the ligand for the LDL receptor. It occurs in plasma as two main isoforms, apoB-48 and apoB-100: the former is synthesized exclusively in the gut and the latter in the liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. Mutations in this gene or its regulatory region cause hypobetalipoproteinemia, normotriglyceridemic hypobetalipoproteinemia, and hypercholesterolemia due to ligand-defective apoB, diseases affecting plasma cholesterol and apoB levels. [provided by RefSeq, Dec 2019]
APOB Gene-Disease associations (from GenCC):
  • hypercholesterolemia, autosomal dominant, type B
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
  • familial hypobetalipoproteinemia 1
    Inheritance: AR, AD, SD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0015838444).
BP6
Variant 2-21002613-C-G is Benign according to our data. Variant chr2-21002613-C-G is described in ClinVar as Benign. ClinVar VariationId is 255977.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.102 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000384.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOB
NM_000384.3
MANE Select
c.12809G>Cp.Arg4270Thr
missense
Exon 29 of 29NP_000375.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOB
ENST00000233242.5
TSL:1 MANE Select
c.12809G>Cp.Arg4270Thr
missense
Exon 29 of 29ENSP00000233242.1

Frequencies

GnomAD3 genomes
AF:
0.0538
AC:
8187
AN:
152068
Hom.:
388
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.104
Gnomad AMI
AF:
0.0219
Gnomad AMR
AF:
0.102
Gnomad ASJ
AF:
0.0616
Gnomad EAS
AF:
0.0318
Gnomad SAS
AF:
0.0155
Gnomad FIN
AF:
0.0355
Gnomad MID
AF:
0.0443
Gnomad NFE
AF:
0.0197
Gnomad OTH
AF:
0.0535
GnomAD2 exomes
AF:
0.0496
AC:
12448
AN:
251068
AF XY:
0.0414
show subpopulations
Gnomad AFR exome
AF:
0.108
Gnomad AMR exome
AF:
0.167
Gnomad ASJ exome
AF:
0.0611
Gnomad EAS exome
AF:
0.0291
Gnomad FIN exome
AF:
0.0371
Gnomad NFE exome
AF:
0.0204
Gnomad OTH exome
AF:
0.0417
GnomAD4 exome
AF:
0.0277
AC:
40532
AN:
1461708
Hom.:
1271
Cov.:
35
AF XY:
0.0264
AC XY:
19231
AN XY:
727156
show subpopulations
African (AFR)
AF:
0.108
AC:
3611
AN:
33460
American (AMR)
AF:
0.162
AC:
7224
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.0620
AC:
1619
AN:
26124
East Asian (EAS)
AF:
0.0372
AC:
1478
AN:
39696
South Asian (SAS)
AF:
0.0133
AC:
1151
AN:
86252
European-Finnish (FIN)
AF:
0.0367
AC:
1962
AN:
53398
Middle Eastern (MID)
AF:
0.0165
AC:
95
AN:
5766
European-Non Finnish (NFE)
AF:
0.0192
AC:
21314
AN:
1111920
Other (OTH)
AF:
0.0344
AC:
2078
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
2071
4142
6213
8284
10355
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
978
1956
2934
3912
4890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0540
AC:
8220
AN:
152186
Hom.:
394
Cov.:
32
AF XY:
0.0546
AC XY:
4060
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.104
AC:
4334
AN:
41514
American (AMR)
AF:
0.103
AC:
1569
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.0616
AC:
214
AN:
3472
East Asian (EAS)
AF:
0.0319
AC:
165
AN:
5176
South Asian (SAS)
AF:
0.0156
AC:
75
AN:
4822
European-Finnish (FIN)
AF:
0.0355
AC:
376
AN:
10594
Middle Eastern (MID)
AF:
0.0476
AC:
14
AN:
294
European-Non Finnish (NFE)
AF:
0.0197
AC:
1337
AN:
68014
Other (OTH)
AF:
0.0549
AC:
116
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
361
722
1084
1445
1806
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0236
Hom.:
63
Bravo
AF:
0.0656
TwinsUK
AF:
0.0170
AC:
63
ALSPAC
AF:
0.0182
AC:
70
ESP6500AA
AF:
0.104
AC:
460
ESP6500EA
AF:
0.0209
AC:
180
ExAC
AF:
0.0456
AC:
5538
Asia WGS
AF:
0.0400
AC:
137
AN:
3478
EpiCase
AF:
0.0165
EpiControl
AF:
0.0167

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
Hypercholesterolemia, familial, 1 (4)
-
-
4
not specified (4)
-
-
2
Familial hypercholesterolemia (2)
-
-
2
not provided (2)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Familial hypobetalipoproteinemia 1 (1)
-
-
1
Hypercholesterolemia, autosomal dominant, type B (1)
-
-
1
Hypercholesterolemia, autosomal dominant, type B;C4551990:Familial hypobetalipoproteinemia 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.76
T
BayesDel_noAF
Benign
-0.72
CADD
Benign
4.9
DANN
Benign
0.50
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.41
N
MetaRNN
Benign
0.0016
T
MetaSVM
Benign
-0.93
T
PhyloP100
0.14
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-1.7
N
REVEL
Benign
0.017
Sift
Benign
0.10
T
Sift4G
Uncertain
0.049
D
Vest4
0.15
MPC
0.049
ClinPred
0.0039
T
GERP RS
-1.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
gMVP
0.46
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1801702; hg19: chr2-21225485; COSMIC: COSV51928353; COSMIC: COSV51928353; API